{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:32:46Z","timestamp":1767990766040,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["NSC 101-2314-B-016-017"],"award-info":[{"award-number":["NSC 101-2314-B-016-017"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["NSC 102-2314-B-016-012"],"award-info":[{"award-number":["NSC 102-2314-B-016-012"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"crossref","award":["TSGH-C102-108"],"award-info":[{"award-number":["TSGH-C102-108"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.clinbiochem.2015.07.001","type":"journal-article","created":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T09:32:11Z","timestamp":1436347931000},"page":"1324-1329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Urokinase plasminogen activator receptor and its soluble form in common biopsy-proven kidney diseases and in staging of diabetic nephropathy"],"prefix":"10.1016","volume":"48","author":[{"given":"Chung-Ze","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Chien","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuh-Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Jen","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dee","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nain-Feng","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Shuen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.clinbiochem.2015.07.001_bb0005","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.4161\/cc.5.16.2994","article-title":"Urokinase-receptor (u-PAR): an essential player in multiple games of cancer: a review on its role in tumor progression, invasion, metastasis, proliferation\/dormancy, clinical outcome and minimal residual disease","volume":"5","author":"Laufs","year":"2006","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.clinbiochem.2015.07.001_bb0010","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/stem.150398","article-title":"Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR","volume":"15","author":"Plesner","year":"1997","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.clinbiochem.2015.07.001_bb0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0014-5793(00)01624-0","article-title":"Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo","volume":"475","author":"Sidenius","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.clinbiochem.2015.07.001_bb0020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1741-7015-10-2","article-title":"suPAR as a prognostic biomarker in sepsis","volume":"10","author":"Donadello","year":"2012","journal-title":"BMC Med."},{"issue":"5","key":"10.1016\/j.clinbiochem.2015.07.001_bb0025","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jinf.2011.07.016","article-title":"Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis","volume":"63","author":"Savva","year":"2011","journal-title":"J. Infect."},{"issue":"14\u201315","key":"10.1016\/j.clinbiochem.2015.07.001_bb0030","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.clinbiochem.2011.07.006","article-title":"The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in systemic inflammatory response syndrome","volume":"44","author":"Yilmaz","year":"2011","journal-title":"Clin. Biochem."},{"issue":"6","key":"10.1016\/j.clinbiochem.2015.07.001_bb0035","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/ki.1996.523","article-title":"Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney","volume":"50","author":"Xu","year":"1996","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.clinbiochem.2015.07.001_bb0040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lab.2004.04.002","article-title":"Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor","volume":"144","author":"Kenichi","year":"2004","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.clinbiochem.2015.07.001_bb0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm1696","article-title":"Modification of kidney barrier function by the urokinase receptor","volume":"14","author":"Wei","year":"2008","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.clinbiochem.2015.07.001_bb0050","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis","volume":"17","author":"Wei","year":"2011","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.clinbiochem.2015.07.001_bb0055","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.thromres.2006.03.011","article-title":"Excess soluble urokinase-type plaminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity","volume":"119","author":"Pawlak","year":"2007","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.clinbiochem.2015.07.001_bb0060","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1464-5491.2011.03513.x","article-title":"The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men","volume":"29","author":"Haugaard","year":"2012","journal-title":"Diabet. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.clinbiochem.2015.07.001_bb0065","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.2337\/dc14-S014","article-title":"Standards of medical care in diabetes\u20142014","volume":"37","author":"American Diabetes Association","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinbiochem.2015.07.001_bb0070","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"issue":"18","key":"10.1016\/j.clinbiochem.2015.07.001_bb0075","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.clinbiochem.2012.07.115","article-title":"Estimating glomerular filtration rate (GFR) in diabetes: the performance of MDRD and CKD-EPI equations in patients with various degrees of albuminuria","volume":"45","author":"Vu\u010di\u0107 Lovren\u010di\u0107","year":"2012","journal-title":"Clin. Biochem."},{"issue":"Suppl. 1","key":"10.1016\/j.clinbiochem.2015.07.001_bb0080","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.2337\/dc15-S012","article-title":"Microvascular complications and foot care","volume":"38","author":"American Diabetes Association","year":"2015","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.clinbiochem.2015.07.001_bb0085","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.clinbiochem.2015.07.001_bb0090","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s00125-013-2914-0","volume":"56","author":"Heraclides","year":"2013","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.clinbiochem.2015.07.001_bb0095","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2796.2010.02252.x","article-title":"Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population","volume":"268","author":"Eugen-Olsen","year":"2010","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.clinbiochem.2015.07.001_bb0100","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/ki.2013.505","article-title":"The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis","volume":"85","author":"Meijers","year":"2014","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.clinbiochem.2015.07.001_bb0105","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/ki.2013.544","article-title":"A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease","volume":"85","author":"Wada","year":"2014","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.clinbiochem.2015.07.001_bb0110","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/ki.2013.546","article-title":"Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children","volume":"85","author":"Sinha","year":"2014","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.clinbiochem.2015.07.001_bb0115","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2215\/CJN.07680712","article-title":"Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report","volume":"8","author":"Bock","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."}],"updated-by":[{"DOI":"10.1016\/j.clinbiochem.2016.07.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000}}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912015002623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912015002623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T12:50:02Z","timestamp":1589547002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912015002623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":23,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0009912015002623"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.07.001","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.clinbiochem.2016.07.001","asserted-by":"object"}]},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urokinase plasminogen activator receptor and its soluble form in common biopsy-proven kidney diseases and in staging of diabetic nephropathy","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}